Drug Type TIL therapy |
Synonyms HS-IT201 |
Target- |
Action- |
Mechanism Lymphocyte replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseEarly Phase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Malignant Solid Neoplasm | Phase 1 | - | 01 Oct 2024 | |
| Digestive System Neoplasms | Phase 1 | China | - | |
| Head and Neck Neoplasms | Phase 1 | China | - | |
| Non-Small Cell Lung Cancer | Phase 1 | China | - | |
| Urologic Neoplasms | Phase 1 | China | - |





